UBS Reiterates Neutral Rating on Adient (ADNT)

August 12, 2025 9:12 AM UTC Send to a Friend
UBS analyst Joseph Spak reiterated a Neutral rating and $26.00 price target on Adient (NYSE: ADNT).The analyst commented, "On the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login